35 TABLE4.2 WA ~CN FACIUiS‘IO ~ “iU3UKlW’( X’TISSWI , ~137 initial IXE(resn)KR TO DIFflXWf~ClX5(F~y_’/ Liver Rd C.E. D.E.b/ Radimuclide & pried ‘ “INITIAL DAILYINTAKE(~/d)” !urrkes = Like C. E.D.E 1.7 E*[ 1.8 E-5 0-30 ywlr 3.7 E-4 3.8 E-5 3&70 year 2.2 E-4 2.4 E+ 4.7 H 2.4 E-4 1.8 E+ 5.3 E-4 1.8 E-6 9.2 E-4 5.0 E-3 3.6 E-5 1.1 E-2 3.6 E-5 5.6 R-4 3.0 B-3 2.2 E+ 6.6 E-3 2.2 E+ 1.3 E-3 1.9 E-3 1.0 E-8 2.4 E-2 4.2 E-3 0-30 year 3.9 E-2 5.7 E-2 3.1 E-7 7.3 E-1 1.3 E-1 3&70 year 5.1 E-2 1.4 E-2 4.1 E-7 9.6 E-1 1.7 E-1 Nmwnlf-wl initial year 1.3 E-3 0-30 year 3.9 E-2 E-6 7.3 E-1 1.3 E-1 year mtcmnl+w initial year CE30 year 30-70 per mJ’mnm-239.-24o initial year ! I I Like plutmiuu 5.7 E-2 I 1.6 30-70 ~ ~ me~ - f- h IXS@-dday. It is,SPCXI~lY. W m lE@B (1987) uhicb pvvides factors in Sv/Bq (= 3.8 x redpimcurie), d is mm.sten t uith ICS@~tiats (ICRFI.986, 1987) .~fwtors aUwforthefractimof ~ABSl@K) FPK14t&gut, its distri&tim 8mfmsiderce timeinti lxxiy, tbe -i~ ~ effe~ d its zadiaticn in the lxxly, md iti rate of p@sical ~. bj CXsmitted effective &se equivalent (wlmle-body dose). Other dcses are ccamitted &se equivakats (tissue&se). The C.E.D.E. is~smof tidcxwequivalents till tissues of tbebody ofastardard aan, eachueighted bytkm2risk resulting frmaunit&3etn that t~asmto tirigkfrwn aunit betotb tile body. c1 E+ signifies: x 1V5.